MyBody-X angle on TSH Genetik

Regarding TSH genetics in the context of MyBody-X, an honest assessment is needed: no specific product details for a TSH gene test are provided in the available context. In general, genetic tests for TSH (e.g., PDE8B, TSHR, CAPZB) examine common variants linked to small differences in baseline TSH levels (GWAS-based, moderate effect sizes). These can indicate a genetic predisposition but do not replace clinical TSH measurement. The evidence is primarily GWAS-supported (human-moderate), insufficient for diagnosis or treatment decisions. MyBody-X may include such markers in a comprehensive DNA test, but without confirmation this remains speculative. Importantly, any genetic finding should be followed up with blood tests (TSH, fT3, fT4) and medical evaluation. Consumer DNA analysis has limitations – it indicates risk, not disease. Therefore, evidence should be rated as 'unclear' or 'marketing' until exact test contents are disclosed.